HSD11B1

Summary

Gene Symbol: HSD11B1
Description: hydroxysteroid (11-beta) dehydrogenase 1
Alias: 11-DH, 11-beta-HSD1, HDL, HSD11, HSD11B, HSD11L, SDR26C1, corticosteroid 11-beta-dehydrogenase isozyme 1, short chain dehydrogenase/reductase family 26C, member 1
Species: human

Top Publications

  1. ncbi 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response
    Jeremy W Tomlinson
    Endocrinology, Division of Medical Sciences, University of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham, B15 2TH, UK
    Endocr Rev 25:831-66. 2004
  2. ncbi Adipose tissue 11beta-hydroxysteroid dehydrogenase type 1 expression in obesity and Cushing's syndrome
    Barbara Mariniello
    Division of Endocrinology, School of Medicine, University of Padur, Via Ospedale 105, 35128 Padua, Italy
    Eur J Endocrinol 155:435-41. 2006
  3. ncbi Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss
    Stefan Engeli
    HELIOS Klinikum Berlin, Franz Volhard Clinic, Medical Faculty of the Charite, Humboldt University of Berlin, Berlin, Germany
    Obes Res 12:9-17. 2004
  4. ncbi Omental adipose tissue type 1 11 beta-hydroxysteroid dehydrogenase oxoreductase activity, body fat distribution, and metabolic alterations in women
    Alain Veilleux
    Department of Food Science and Nutrition, Laval University, Quebec, Canada
    J Clin Endocrinol Metab 94:3550-7. 2009
  5. ncbi Lack of Association of the 11beta-hydroxysteroid dehydrogenase type 1 gene 83,557insA and hexose-6-phosphate dehydrogenase gene R453Q polymorphisms with body composition, adrenal androgen production, blood pressure, glucose metabolism, and dementia
    Pauline Smit
    Department of Internal Medicine, Room Ee530C, Erasmus Medical Center, Dr Molewaterplein 40, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    J Clin Endocrinol Metab 92:359-62. 2007
  6. ncbi Expression profiling of 11beta-hydroxysteroid dehydrogenase type-1 and glucocorticoid-target genes in subcutaneous and omental human preadipocytes
    I J Bujalska
    Division of Medical Sciences, The Medical School, Institute of Biomedical Research, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
    J Mol Endocrinol 37:327-40. 2006
  7. ncbi Depot-specific regulation of the conversion of cortisone to cortisol in human adipose tissue
    Mi Jeong Lee
    Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland at Baltimore, Baltimore, Maryland, USA
    Obesity (Silver Spring) 16:1178-85. 2008
  8. ncbi Genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome
    Alessandra Gambineri
    Division of Endocrinology, Department of Internal Medicine, S Orsola Malpighi Hospital, Via Massarenti 9, 40138 Bologna, Italy
    J Clin Endocrinol Metab 91:2295-302. 2006
  9. ncbi 11Beta-hydroxysteroid dehydrogenase type 1 in differentiating omental human preadipocytes: from de-activation to generation of cortisol
    Iwona J Bujalska
    Division of Medical Sciences, University of Birmingham, Queen Elizabeth Hospital, Birmingham B15 2TH, UK
    Endocr Res 28:449-61. 2002
  10. ncbi Upregulation of adipose 11-beta-hydroxysteroid dehydrogenase type 1 expression in ovariectomized rats is due to obesity rather than lack of estrogen
    Søren K Paulsen
    Department of Endocrinology and Metabolism C, Aarhus University Hospital, Aarhus Sygehus, Tage Hansens Gade, Aarhus C, Denmark
    Obesity (Silver Spring) 16:731-5. 2008

Research Grants

  1. THE ATHEROPROTECTIVE EFFECTS OF SR-BI
    Monty Krieger; Fiscal Year: 2004
  2. Apo E mimetics reduce cholesterol and improve HDL function
    G M Anantharamaiah; Fiscal Year: 2010
  3. Structure of apolipoprotein A-I on defined states of HDL
    MICHAEL NOBUAKI ODA; Fiscal Year: 2010
  4. Asthma Increases Vaso-occlusion in Sickle Cell Disease
    KIRKWOOD A contact PRITCHARD; Fiscal Year: 2010
  5. Dynamics of LCAT activation and lipoprotein remodeling
    Jere P Segrest; Fiscal Year: 2011
  6. SR-BI: INFLUENCE OF APOA-II
    DENEYS VAN DER WESTHUYZEN; Fiscal Year: 2003
  7. Apolipoprotein A-I structure in high density lipoproteins
    W Davidson; Fiscal Year: 2007
  8. Apolipoprotein A-I structure in high density lipoproteins
    W Sean Davidson; Fiscal Year: 2010
  9. Structural Plasticity of ApoAI & Lipid-binding Activity
    Jianjun Wang; Fiscal Year: 2007
  10. Structural Plasticity of ApoAI & Lipid-binding Activity
    Jianjun Wang; Fiscal Year: 2009

Detail Information

Publications241 found, 100 shown here

  1. ncbi 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response
    Jeremy W Tomlinson
    Endocrinology, Division of Medical Sciences, University of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham, B15 2TH, UK
    Endocr Rev 25:831-66. 2004
    ..quot;11beta-HSD1 knockout state" in humans, has been defined and is caused by intronic mutations in HSD11B1 that decrease gene transcription together with mutations in hexose-6-phosphate dehydrogenase, an endoluminal ..
  2. ncbi Adipose tissue 11beta-hydroxysteroid dehydrogenase type 1 expression in obesity and Cushing's syndrome
    Barbara Mariniello
    Division of Endocrinology, School of Medicine, University of Padur, Via Ospedale 105, 35128 Padua, Italy
    Eur J Endocrinol 155:435-41. 2006
    ..To evaluate the expression of 11beta-hydrxysteroid dehydrogenase type 1 (11beta-HSD1) in omental adipose tissue of patients with Cushing's syndrome and simple obesity, compared with normal weight controls...
  3. ncbi Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss
    Stefan Engeli
    HELIOS Klinikum Berlin, Franz Volhard Clinic, Medical Faculty of the Charite, Humboldt University of Berlin, Berlin, Germany
    Obes Res 12:9-17. 2004
    ..The aim of this study was to determine whether up-regulation of human adipose 11beta-HSD1 in obesity can also be found at the gene expression level...
  4. ncbi Omental adipose tissue type 1 11 beta-hydroxysteroid dehydrogenase oxoreductase activity, body fat distribution, and metabolic alterations in women
    Alain Veilleux
    Department of Food Science and Nutrition, Laval University, Quebec, Canada
    J Clin Endocrinol Metab 94:3550-7. 2009
    ....
  5. ncbi Lack of Association of the 11beta-hydroxysteroid dehydrogenase type 1 gene 83,557insA and hexose-6-phosphate dehydrogenase gene R453Q polymorphisms with body composition, adrenal androgen production, blood pressure, glucose metabolism, and dementia
    Pauline Smit
    Department of Internal Medicine, Room Ee530C, Erasmus Medical Center, Dr Molewaterplein 40, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    J Clin Endocrinol Metab 92:359-62. 2007
    ..was proposed that a combination of the 83,557insA polymorphism in the 11beta-hydroxysteroid dehydrogenase type 1 (HSD11B1) gene and the R453Q polymorphism in the hexose-6-phosphate dehydrogenase (H6PD) gene interacts to cause cortisone ..
  6. ncbi Expression profiling of 11beta-hydroxysteroid dehydrogenase type-1 and glucocorticoid-target genes in subcutaneous and omental human preadipocytes
    I J Bujalska
    Division of Medical Sciences, The Medical School, Institute of Biomedical Research, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
    J Mol Endocrinol 37:327-40. 2006
    ..The Affymetrix data have been confirmed by quantitative real-time PCR for ten specific genes, including HSD11B1, GR, C/EBPalpha, C/EBPbeta, IL-6, FABP4, APOD, IRS2, AGTR1 and GHR...
  7. ncbi Depot-specific regulation of the conversion of cortisone to cortisol in human adipose tissue
    Mi Jeong Lee
    Division of Endocrinology, Diabetes and Nutrition, Department of Medicine, University of Maryland at Baltimore, Baltimore, Maryland, USA
    Obesity (Silver Spring) 16:1178-85. 2008
    ..Our main objective was to compare the regulation of cortisol production within omental (Om) and abdominal subcutaneous (Abd sc) human adipose tissue...
  8. ncbi Genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome
    Alessandra Gambineri
    Division of Endocrinology, Department of Internal Medicine, S Orsola Malpighi Hospital, Via Massarenti 9, 40138 Bologna, Italy
    J Clin Endocrinol Metab 91:2295-302. 2006
    ..11beta-HSD1 deficiency may protect against obesity and its metabolic consequences because of impaired regeneration of cortisol in adipose tissue...
  9. ncbi 11Beta-hydroxysteroid dehydrogenase type 1 in differentiating omental human preadipocytes: from de-activation to generation of cortisol
    Iwona J Bujalska
    Division of Medical Sciences, University of Birmingham, Queen Elizabeth Hospital, Birmingham B15 2TH, UK
    Endocr Res 28:449-61. 2002
    ..The differences in set-point of 11beta-HSD1 activity between OM and SC human adipose tissue may be an important factor in the pathogenesis of visceral obesity...
  10. ncbi Upregulation of adipose 11-beta-hydroxysteroid dehydrogenase type 1 expression in ovariectomized rats is due to obesity rather than lack of estrogen
    Søren K Paulsen
    Department of Endocrinology and Metabolism C, Aarhus University Hospital, Aarhus Sygehus, Tage Hansens Gade, Aarhus C, Denmark
    Obesity (Silver Spring) 16:731-5. 2008
    ..Estrogen suppresses hepatic and renal 11beta-HSD1 in rats; hence we investigated the in vitro effect of estrogen on human and rat AT, and the in vivo effects on rat AT 11beta-HSD1 expression...
  11. ncbi Growth hormone (GH) substitution in GH-deficient patients inhibits 11beta-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression in adipose tissue
    Søren Kildeberg Paulsen
    Department of Endocrinology and Metabolism C, Aarhus University Hospital, Aarhus Sygehus, Tage Hansensgade 2, DK 8000 Aarhus C, Denmark
    J Clin Endocrinol Metab 91:1093-8. 2006
    ..Increased tissue activity of cortisol may play a central role in the features of GH deficiency and the metabolic syndrome...
  12. ncbi The contribution of visceral adipose tissue to splanchnic cortisol production in healthy humans
    Ruth Andrew
    Endocrinology Unit, School of Molecular and Clinical Medicine, University of Edinburgh, Western General Hospital, Edinburgh, EH4 2XU, UK
    Diabetes 54:1364-70. 2005
    ..Thus, in addition to free fatty acids and adipokines, the portal vein delivers cortisol to the liver, and inhibition of 11HSD1 in visceral adipose tissue may indeed be valuable in ameliorating insulin resistance in obesity...
  13. ncbi 11beta-Hydroxysteroid dehydrogenase expression and glucocorticoid synthesis are directed by a molecular switch during osteoblast differentiation
    M Eijken
    Department Internal Medicine, Erasmus Medical Center, Room Ee526, P O Box 1738, 3000 DR, Rotterdam, The Netherlands
    Mol Endocrinol 19:621-31. 2005
    ..This efficient mechanism by which osteoblasts generate cortisol in an autocrine fashion to ensure proper differentiation will help to understand the complex effects of cortisol on bone metabolism...
  14. ncbi Weight loss increases 11beta-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue
    Jeremy W Tomlinson
    Division of Medical Sciences, Queen Elizabeth Hospital, University of Birmingham, Birmingham, United Kingdom B15 2TH
    J Clin Endocrinol Metab 89:2711-6. 2004
    ..Inhibition of 11betaHSD1 may therefore be a novel, therapeutic strategy for insulin sensitization...
  15. ncbi Altered activity of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in skeletal muscle confers metabolic protection in subjects with type 2 diabetes
    Christina Jang
    Department of Endocrinology and Diabetes, St Vincent s Hospital, Melbourne, 41 Victoria Parade, Fitzroy 3065, Australia
    J Clin Endocrinol Metab 92:3314-20. 2007
    ..There is little information regarding the regulation of 11beta-hydroxysteroid dehydrogenase (11beta-HSD) enzymes in skeletal muscle in the setting of type 2 diabetes...
  16. ncbi 11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess
    P C White
    Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas 75235 9063, USA
    Endocr Rev 18:135-56. 1997
    ..Mutations in the HSD11B2 (HSD11K) gene encoding the kidney isozyme of 11-HSD have been detected in all kindreds with AME studied thus far. This gene represents a candidate locus for the common, "essential" form of hypertension...
  17. ncbi Impaired glucose tolerance and insulin resistance are associated with increased adipose 11beta-hydroxysteroid dehydrogenase type 1 expression and elevated hepatic 5alpha-reductase activity
    Jeremy W Tomlinson
    Division of Medical Sciences, Institute of Biomedical Research, University of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham, U K
    Diabetes 57:2652-60. 2008
    ....
  18. ncbi 11beta-Hydroxysteroid Dehydrogenase Type 1 Regulation by Intracellular Glucose 6-Phosphate Provides Evidence for a Novel Link between Glucose Metabolism and Hypothalamo-Pituitary-Adrenal Axis Function
    Elizabeth A Walker
    Endocrinology, Division of Medical Sciences and Biological Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom
    J Biol Chem 282:27030-6. 2007
    ..The cellular trafficking of G6P therefore directly regulates 11beta-HSD1 reductase activity and provides a novel link between glucose metabolism and function of the hypothalamo-pituitary-adrenal axis...
  19. ncbi Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians
    Robert S Lindsay
    National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Department of Health and Human Services, Phoenix, Arizona 85016, USA
    J Clin Endocrinol Metab 88:2738-44. 2003
    ..Our data support the hypothesis that increased regeneration of cortisol in adipose tissue influences metabolic sequelae of human obesity...
  20. ncbi Risk stratification in hypertension: new insights from the Framingham Study
    W B Kannel
    Department of Epidemiology and Preventive Medicine, Medicine and Public Health, Boston University School of Medicine, Massachusetts 01702, USA
    Am J Hypertens 13:3S-10S. 2000
    ..and dislipidemia (elevated total, LDL, and small dense LDL cholesterol levels, raised triglyceride, and reduced HDL cholesterol levels)...
  21. ncbi Pattern of 11 beta-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression in the ovine uterus during the estrous cycle and pregnancy
    K Yang
    Lawson Research Institute, St Joseph s Hospital, Departments of Ob Gyn and Physiology, University of Western Ontario, London, Canada
    Biol Reprod 55:1231-6. 1996
    ..Since circulating levels of progesterone are elevated during both of these periods, the present findings suggest a progesterone effect on uterine 11 beta-HSD1 gene expression...
  22. ncbi Ethnic differences in red blood cell sodium/lithium countertransport and metabolic correlates of hypertension: an international collaborative study
    E Ragone
    Department of Clinical and Experimental Medicine, Federico II University of Naples Medical School, Italy
    Am J Hypertens 11:935-41. 1998
    ..001), had a lower HDL/total cholesterol ratio (P < .01), an elevated fasting blood glucose (P < ...
  23. ncbi Apolipoprotein E2 transgenic rabbits. Modulation of the type III hyperlipoproteinemic phenotype by estrogen and occurrence of spontaneous atherosclerosis
    Y Huang
    Gladstone Institute of Cardiovascular Disease, Cardiovascular Research Institute, University of California, San Francisco, California 94141-9100, USA
    J Biol Chem 272:22685-94. 1997
    ..Only females had increased high density lipoproteins (HDL) (40%), which were shifted from typical small HDL to larger HDL1...
  24. ncbi Genetic basis of familial dyslipidemia and hypertension: 15-year results from Utah
    R R Williams
    Department of Internal Medicine, University of Utah Cardiovascular Genetics Research Clinic, Salt Lake City 84108
    Am J Hypertens 6:319S-327S. 1993
    ..also found for low-density lipoprotein (LDL) cholesterol, lipoprotein (a) (Lp[a]), low high-density lipoprotein (HDL) cholesterol, and high apolipoprotein (apo) B...
  25. ncbi Established risk factors and coronary artery disease: the Framingham Study
    P W Wilson
    Framingham Heart Study, MA 01701
    Am J Hypertens 7:7S-12S. 1994
    ..of coronary artery disease (CAD) have typically included age, blood levels of total and high-density lipoprotein (HDL) cholesterol, blood pressure, cigarette use, diabetes mellitus, and left ventricular hypertrophy on ..
  26. ncbi Effect of testosterone replacement on whole body glucose utilisation and other cardiovascular risk factors in males with idiopathic hypogonadotrophic hypogonadism
    D Tripathy
    Department of Endocrinology, All India Institute of Medical Sciences, New Delhi
    Horm Metab Res 30:642-5. 1998
    ..5 [13.4] vs 91.6 [5.0], p=0.04; 65.9 [9.9] vs 39.4 [7.3], p=0.05); Ratio of total cholesterol to HDL ratio also decreased significantly (p=0.05). Changes of serum triglycerides (p=0.25) and HDL cholesterol (p=0...
  27. ncbi Physical activity and relationship with coronary heart disease risk factors
    P N Adamopoulos
    Preventive Medicine Unit, Alexandra Hospital, Athens, Hellas
    Acta Cardiol 48:523-34. 1993
    ..0971, p = 0.0185), total lipids (r = +0.0927, p = 0.0246), high density lipoprotein-cholesterol (HDL-C) concentration in mg/dl (r = +0.0842, p = 0...
  28. ncbi Metabolic abnormalities following heart transplantation in patients with idiopathic cardiomyopathy
    W H Sheu
    Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan ROC
    Horm Metab Res 27:469-72. 1995
    ..patients; eight of the 15 patients had a plasma cholesterol > 5 mmol/l, nine had a high density lipoprotein (HDL)-cholesterol concentration < 1 mmol/l, and nine had a ratio of total to HDL-cholesterol > 5.0...
  29. ncbi The clinical heterogeneity of hypertension
    W B Kannel
    Section of Preventive Medicine and Epidemiology, Boston University School of Medicine, Massachussetts 02118
    Am J Hypertens 4:283-7. 1991
    ..Hypertensive patients at particularly increased risk of cardiovascular events are those with an increased total/HDL-cholesterol ratio, ECG abnormality, impaired glucose tolerance, or the cigarette smoking habit...
  30. ncbi Changes in nutritional pattern, insulin sensitivity and glucose tolerance during weight loss in obese patients from a Mediterranean area
    A L Calle-Pascual
    Servicio de Endocrinologia y Nutricion, Hospital Universitario San Carlos, Madrid,
    Horm Metab Res 27:499-502. 1995
    ..Weight, body mass index (BMI). waist-to-hip ratio (WHR), blood pressure (BP), cholesterol, HDL-c, LDL-c, triglycerides, fasting and 2 h-post glucose load plasma glucose were determined at the onset and at the ..
  31. ncbi The patient at risk: who should we be treating?
    I Shviro
    Center for Research, Prevention and Treatment of Atherosclerosis, Hadassah University Hospital, Jerusalem, Israel
    Br J Clin Pract Suppl 77:24-7. 1996
    ..in group 2 showed a reduction in plasma LDL-C levels of 35% and in LDL-C to high-density lipoprotein cholesterol (HDL-C) ratio of 45% compared with 32% and 38% respectively in group 1...
  32. ncbi Effects of swim training on body weight, carbohydrate metabolism, lipid and lipoprotein profile
    H Tanaka
    Exercise Science Unit, University of Tennessee-Knoxville, Knoxville, TN 37996-2700, USA
    Clin Physiol 17:347-59. 1997
    ..Total, high-density lipoprotein (HDL)- and low-density lipoprotein (LDL)-cholesterol did not change significantly in either group...
  33. ncbi Apolipoprotein E genotypes and metabolic risk factors for coronary heart disease in middle-aged women
    M Cubrilo-Turek
    Internal Clinics, General Hospital Sveti Duh, Zagreb, Croatia
    Coll Antropol 22:149-55. 1998
    Apo E genotypes and plasma metabolic risk factors (total cholesterol, triglycerides, HDL and LDL cholesterol, total/HDL cholesterol ratio, lipoprotein Lp (a), apolipoprotein A-I, A-II, apo B, and apo E) were determined in 134 healthy ..
  34. ncbi [Impact of controlling risk factors after myocardial infarction]
    L Guize
    , , Paris
    Arch Mal Coeur Vaiss 88:51-7. 1995
    ..A low HDL-c concentration should lead to more energetic reduction of LDL-c and control of smoking, obesity and sedentarity...
  35. ncbi Hyperapobetalipoproteinemia with compositional abnormality of LDL and IDL, a characteristic lipoprotein alteration in essential hypertension
    K I Ryomoto
    The Department of Atherosclerosis, Metabolism and Clinical Nutrition, and Research Institute, National Cardiovascular Center, Osaka, Japan
    Am J Hypertens 13:617-24. 2000
    ..VLDL, IDL, LDL, and high-density lipoprotein (HDL) were separated by ultracentrifugation in the 23 hypertensive and 17 healthy subjects (control group)...
  36. ncbi Coronary heart disease risk factors and cigarette smoking among rural African Americans
    J P Willems
    Department of Internal Medicine, University of Virginia Health Sciences Center, Charlottesville 22908, USA
    J Natl Med Assoc 89:37-47. 1997
    Cigarette smoking has been reported to worsen high-density lipoprotein (HDL) cholesterol and other cardiac risk factors, yet no studies have examined this issue among rural African Americans...
  37. ncbi The diet and moderate exercise trial (DAMET): results after 24 weeks
    R B Singh
    Heart Research Laboratory, Medical Hospital and Research Centre, Morabadad, India
    Acta Cardiol 47:543-57. 1992
    ..9%) and LDL-cholesterol (6.7%) and triglycerides (11.9%) and a marked increase in HDL-cholesterol (16.5%)...
  38. ncbi Correlation between plasma lipoprotein Lp(a) and sex hormone concentrations: a cross-sectional study in healthy males
    L Denti
    Chair of Gerontology and Geriatrics, University of Parma, Italy
    Horm Metab Res 26:602-8. 1994
    ..As for the other lipoproteins, a positive correlation between HDL-cholesterol and E2 and an inverse correlation between triglycerides and SHBG were observed...
  39. ncbi Serotonin-immune interactions in major depression: lower serum tryptophan as a marker of an immune-inflammatory response
    M Maes
    Clinical Research Center for Mental Health (CRC-MH, University Department of Psychiatry, Antwerp, Belgium
    Eur Arch Psychiatry Clin Neurosci 247:154-61. 1997
    ..Zn), total serum protein (TSP), albumin (Alb), transferrin (Tf), iron (Fe), high-density lipoprotein cholesterol (HDL-C), number of peripheral blood leukocytes, and the CD4+/CD8+ T cell (T-helper/T-suppressor) ratio...
  40. ncbi Long-term effects of simvastatin in hypercholesterolemic patients with NIDDM and additional atherosclerotic risk factors. Hyogo Simvastatin Study Group
    T Kazumi
    Department of Medicine, Hyogo Medical Center for Adults, Akashi, Japan
    Horm Metab Res 27:239-43. 1995
    ..b>HDL cholesterol increased significantly in the nondiabetic group but not in the diabetic group...
  41. ncbi Dental status, diet and cardiovascular risk factors in middle-aged people in northern Sweden
    I Johansson
    Department of Nutritional Research, , Sweden
    Community Dent Oral Epidemiol 22:431-6. 1994
    ..Edentulous men and women were more obese and had lower serum HDL-cholesterol concentrations than those with remaining teeth...
  42. ncbi Effect of insulin on renal sodium and uric acid handling in essential hypertension
    E Muscelli
    Metabolism Unit, C.N.R. Institute of Clinical Physiology, Pisa, Italy
    Am J Hypertens 9:746-52. 1996
    ..35, P < .05), and serum triglyceride levels (r = 0.59, P = .0001), and negatively related to HDL cholesterol concentrations (r = -0.59, P = .0001) and glucose disposal rate (r = 0.42, P < .01)...
  43. ncbi [Microalbuminuria in hypertensive, non-proteinuric renal transplant recipients: role of previous acute rejection episodes and sodium intake]
    J M Halimi
    , , , 37044 Tours
    Arch Mal Coeur Vaiss 94:933-6. 2001
    ..SAP) and diastolic (DAP) arterial pressure, total cholesterol, triglycerides, fasting glucose and body weight, low HDL-cholesterol) and may be a marker of cardiovascular and renal risk in the general population...
  44. ncbi alpha-Tocopherol and beta-carotene serum levels in post-menopausal women treated with transdermal estradiol and oral medroxyprogesterone acetate
    C Clemente
    Laboratory of Biochemistry, IRCCS S. De Bellis, Castellana G, Italy
    Horm Metab Res 28:558-61. 1996
    ..It is well known that hormone replacement therapy (HRT) can effectively decrease LDL-cholesterol and increase HDL-cholesterol and Apo-Al serum levels...
  45. ncbi Lipid metabolism in lipoatrophic diabetes
    G Enzi
    Department of Internal Medicine, University of Padua, Italy
    Horm Metab Res 20:587-91. 1988
    ..composition, expressed as mg/dl, demonstrates a significant increase of VLDL mass and a significant reduction of HDL mass...
  46. ncbi Hypertension and other cardiovascular risk factors in women
    N K Wenger
    Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA
    Am J Hypertens 8:94s-99s. 1995
    ..Young to middle aged women have higher HDL cholesterol and lower LDL cholesterol levels than men...
  47. ncbi [Effects of deprivation and replacement by percutaneous 17 beta estradiol and oral progesterone on blood pressure and metabolic parameters in menopause patients with non-insulin-dependent diabetes]
    H Mosnier-Pudar
    , , Paris
    Arch Mal Coeur Vaiss 84:1111-5. 1991
    ..There was also no change in plasma levels of total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides and apolipoproteins A1 and B...
  48. ncbi [Carotid artery thrombosis and myocardial infarction in nephrotic syndrome]
    J Nigond
    Service de cardiologie,
    Arch Mal Coeur Vaiss 83:105-8. 1990
    ..VLDL) or both; contradictory results have been reported with respect to the high density lipoproteins (HDL): decreased, normal or even increased plasma levels have been observed...
  49. ncbi Risk variables of insulin resistance syndrome in African-American and Caucasian young adults with microalbuminuria: the Bogalusa Heart Study
    S R Srinivasan
    Tulane Center for Cardiovascular Health, Department of Epidemiology, New Orleans, Louisiana 70112, USA
    Am J Hypertens 13:1274-9. 2000
    ..include body mass index, waist circumference, blood pressure (BP), triglycerides, high-density lipoprotein (HDL) cholesterol, glucose, insulin, insulin resistance index (calculated from a homeostasis model assessment equation), ..
  50. ncbi Lipoprotein lipase and cholesterol transfer activities of lean and obese Zucker rats
    J Peinado-Onsurbe
    Centre de Recerca en Nutrició i Ciència dels Aliments, Facultat de Biologia, Universitat de Barcelona, Av Diagonal 645, 08028 Barcelona, Spain
    Horm Metab Res 33:458-62. 2001
    ..significant differences were found for lecithin-cholesterol acyltransferase activity, except when the levels in the HDL fraction were expressed per unit of protein weight, showing lower activity in the obese rats...
  51. ncbi Protection by scoparone against the alterations of plasma lipoproteins, vascular morphology and vascular reactivity in hyperlipidaemic diabetic rabbit
    H C Huang
    Department of Pharmacology, College of Medicine, National Taiwan University, Taipei
    Br J Pharmacol 110:1508-14. 1993
    ..low-density lipoprotein (VLDL) cholesterol, low density lipoprotein (LDL) cholesterol and high-density lipoprotein (HDL) cholesterol were markedly increased as soon as the rabbit became diabetic at the second week...
  52. ncbi Plasma lipids, HDL and apolipoproteins, and coronary heart disease in men less than 50 years old. A case-control study
    G I Cubero
    Servicio de Cardiologia, Hospital Universitario Central de Asturias, Oviedo, Spain
    Acta Cardiol 53:269-73. 1998
    ..Plasma concentrations of total cholesterol (TChol), HDL-cholesterol (HDLChol), triglycerides (TG), apoproteins A1 and B and Lp(a) were determined...
  53. ncbi Determinants of physical performance at cycloergometer in healthy middle aged men in Italy. The ECCIS project. Epidemiology and Clinics of Silent Ischemic Heart Disease
    F Seccareccia
    Laboratorio di Epidemiologia Biostatistica, , Rome, Italy
    Acta Cardiol 52:49-65. 1997
    ..b>HDL and non-HDL cholesterol, a score of physical exercise and cigarette consumption...
  54. ncbi Effects of n-3 fatty acids in essential hypertension
    P D Levinson
    Department of Medicine, Brown University, Providence, Rhode Island
    Am J Hypertens 3:754-60. 1990
    ..triglycerides declined (by approximately 30%) in patients receiving only marine oil, but total cholesterol, LDL-, HDL-, HDL2-, and HDL3-cholesterol-subfractions and apolipoproteins A-I and B were unchanged in both treatment groups...
  55. ncbi Short and long-term effects of growth hormone treatment on lipid, lipoprotein, and apolipoprotein levels in short normal children
    C Azzarito
    IIa Divisione di Medicina Interna, Arcispedale S. Maria Nuova, Reggio Emilia, Italy
    Horm Metab Res 26:432-5. 1994
    ..and TG go above normal nor were there any changes in the following tests: high density lipoprotein cholesterol (HDL-C), apolipoprotein (Apo) A-I, Apo B, Apo C-II, Apo C-III and Apo E...
  56. ncbi [Identification of subjects at high risk of coronary disease in a working population using a prediction model]
    D Laurier
    , INSERM U263,
    Arch Mal Coeur Vaiss 88:1569-75. 1995
    ..The modified model enables an estimation of individual coronary risk based on 7 factors: age, total cholesterol, HDL-cholesterol, systolic blood pressure, smoking, diabetes and presence of left ventricular hypertrophy, taking into ..
  57. ncbi Comprehensive nutrition plan improves cardiovascular risk factors in essential hypertension
    D A McCarron
    Department of Medicine, Oregon Health Sciences University, Portland 97201, USA
    Am J Hypertens 11:31-40. 1998
    ..0001), LDL:HDL (P < .001), HbA1c (P < .05), homocysteine (P < .001), total nutrient intake (P < ...
  58. ncbi Red blood cell Na-Li countertransport, hypertensive heredity, and cardiovascular risk in young adults
    J M Krzesinski
    University of Liege, Belgium
    Am J Hypertens 6:314-6. 1993
    ..The Na-Li CT was negatively correlated with the HDL cholesterol (r = -0.37) and the HDL cholesterol/total cholesterol ratio (r = -0.44)...
  59. ncbi Lipoprotein (a) in thyroid dysfunction before and after treatment
    S Spandrio
    Clinica Medica, , Italy
    Horm Metab Res 25:586-9. 1993
    ..001). Also HDL-cholesterol and triglycerides decreased (from 75 +/- 22 mg/dl to 56 +/- 18 mg/dl and from 182 +/- 87 mg/dl to 112 +/..
  60. ncbi The decrease of rat postprandial plasma triacylglycerol concentration after multiple cycles of starvation-refeeding
    Z Kochan
    Department of Biochemistry, Medical University of Gdansk, Poland
    Horm Metab Res 33:26-9. 2001
    ..In contrast, the plasma cholesterol (both total and HDL cholesterol) concentration did not change appreciably either after 1 or 8 cycles of starvation-refeeding as ..
  61. ncbi Efficacy and safety of fluvastatin in hypertensive patients. An analysis of a clinical trial database
    T K Peters
    Department of Clinical Research and Development, Sandoz Pharma Ltd, Basel, Switzerland
    Am J Hypertens 6:340S-345S. 1993
    ..Increases in high-density lipoprotein cholesterol (HDL-C) as well as decreases in triglycerides with fluvastatin were not consistently different between hypertensive and ..
  62. ncbi Pulse wave velocity as an index of arterial stiffness: a comparison between newly diagnosed (untreated) hypertensive and normotensive middle-aged Malay men and its relationship with fasting insulin
    C A Ngim
    School of Medical Science, Universiti Sains Malaysia, Kelantan, Malaysia
    Acta Cardiol 54:277-82. 1999
    ..Other measurements obtained were blood pressure, body mass index, fasting insulin, cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides, glucose and creatinine level...
  63. ncbi Safety and tolerability of fluvastatin with concomitant use of antihypertensive agents. An analysis of a clinical trial database
    T K Peters
    Clinical Research and Development, Sandoz Pharma Ltd, Basel, Switzerland
    Am J Hypertens 6:346S-352S. 1993
    ..The efficacy of fluvastatin in modifying low-density lipoprotein (LDL)- and high-density lipoprotein (HDL)-cholesterol and triglyceride levels was not consistently different in patients taking a given antihypertensive ..
  64. ncbi The effects of glurenorm on plasma glucose and lipids in patients with type 2 diabetes mellitus
    S C Chou
    Department of Internal Medicine, Chang Gung Memorial Hospital, Taipei, Taiwan
    Chang Gung Med J 23:480-4. 2000
    ..054). The total cholesterol, low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) of 14 hypercholesterolemic patients did not change significantly...
  65. ncbi Metabolic effects of doxazosin and enalapril in hypertriglyceridemic, hypertensive men. Relationship to changes in skeletal muscle blood flow
    P E Andersson
    Department of Geriatrics, Samariterhemmets Hospital, Uppsala, Sweden
    Am J Hypertens 9:323-33. 1996
    ..that subjects with an accumulation of risk factors for coronary heart disease (high VLDL triglycerides, low HDL cholesterol and high fasting blood glucose) seemed to benefit most from the metabolic actions of doxazosin ..
  66. ncbi Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II
    A Marzal-Casacuberta
    Department of Cell Biology, Baylor College of Medicine, Houston, Texas, 77030, USA
    J Biol Chem 271:6720-8. 1996
    The concentration of high density lipoproteins (HDL) is inversely related to the risk of atherosclerosis. The two major protein components of HDL are apolipoprotein (apo) A-I and apoA-II...
  67. ncbi Changes in glucose, cholesterol and serum lipid fraction levels in experimental diabetes
    R Maciejewski
    Department of Human Anatomy, Medical University of Lublin
    Ann Univ Mariae Curie Sklodowska Med 56:363-8. 2001
    ..Similar correlation was observed between HDL and total cholesterol concentration on 90th day of the course of disease...
  68. ncbi [Differences between management guidelines and global health strategies for arterial hypertension with metabolic disorders in France in 1999. Ohara study]
    J M Mallion
    CHU Michallon, 38043 Grenoble
    Arch Mal Coeur Vaiss 94:834-8. 2001
    ..Among these hypertensives, measurement of plasma cholesterol was performed in only 61%, HDL-C/LDL-C in 26% and blood glucose in 51%. In the patients with dyslipidemia, LDL-C was measured in only 47%...
  69. ncbi Lipid metabolism and coagulation during the normal menstrual cycle
    A M Lebech
    Department of Gynecology and Obstetrics, Frederiksberg Hospital, Copenhagen, Denmark
    Horm Metab Res 21:445-8. 1989
    ..No significant changes (P greater than 0.05) in lipids and lipoproteins (including the HDL subfractions and apolipoproteins) were found throughout the menstrual cycle...
  70. ncbi Impaired fibrinolysis and insulin resistance in patients with hypertension
    J R Jeng
    Division of Cardiology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Republic of China, Taiwan
    Am J Hypertens 9:484-90. 1996
    ..In addition, PAI-1 activity and tPA antigen were significantly correlated with blood pressure, SSPG, triglyceride, HDL-cholesterol and integrated glucose response to an oral load of 75 g glucose...
  71. ncbi Effects of dicentrine on haemodynamic, plasma lipid, lipoprotein level and vascular reactivity in hyperlipidaemic rats
    S M Yu
    Pharmacological Institute, College of Medicine, National Taiwan University, Taipei
    Br J Pharmacol 108:1055-61. 1993
    ..3. Dicentrine therapy was associated with increased high density lipoprotein (HDL)-cholesterol levels; thus the ratio of total plasma cholesterol to HDL-cholesterol was improved. 4...
  72. ncbi Lipids in rat liver submitted to acute and chronic hyperthyroidism
    S M Varas
    Department of Biochemistry and Biological Sciences, Faculty of Chemistry, Biochemistry and Pharmacy, National University of San Luis, Argentina
    Horm Metab Res 31:514-8. 1999
    ..Serum total cholesterol, HDL-cholesterol and bile acids did not vary among the three groups...
  73. ncbi Elution of lipoprotein fractions containing apolipoproteins E and A-I in size exclusion on Superose 6 columns is sensitive to mobile phase pH and ionic strength
    J Westerlund
    Lipid and Lipoprotein Research Group, University of Alberta, Edmonton, Canada
    J Chromatogr A 718:59-66. 1995
    ..By density ultracentrifugation, apoE and apoA-I were mostly (> 90%) confined to high-density lipoproteins (HDL, d = 1.063-1...
  74. ncbi Properties of a protein from Staphylococcus capitis that binds human serum high density lipoprotein
    A Osland
    Department of Microbiology and Immunology, Gade Institute, University of Bergen, Norway
    Zentralbl Bakteriol Mikrobiol Hyg A 268:435-47. 1988
    A high density lipoprotein (HDL) binding component from the cell wall of Staphylococcus capitis, possessing both HDL binding and HDL precipitating activity, has been partially characterised...
  75. ncbi Cholesterol 7 alpha-hydroxylase activity in hypothyroidism and hyperthyroidism in humans
    G Sauter
    Department of Medicine II, Klinikum Grosshadern, University of Munich, Germany
    Horm Metab Res 29:176-9. 1997
    ..7 +/- 15.8 ng/ml vs 24.5 +/- 18.1 ng/ml before treatment, n.s.) as well as serum HDL-cholesterol were unchanged during substitution therapy...
  76. ncbi Fish oil supplementation versus gemfibrozil treatment in hyperlipidemic NIDDM. A randomized crossover study
    P Fasching
    Department of Medicine III, University of Vienna, AKH, Austria
    Horm Metab Res 28:230-6. 1996
    ..S.); VLDL-TG, -44***/-27** (N.S.); (p vs. baseline: * < 0.05, ** < 0.01, *** < 0.001). Total-HDL, HDL2, HDL3 and APO A were not influenced by either FO or G...
  77. ncbi Hepatocyte damage induced by carbon tetrachloride: inhibited lipoprotein secretion and changed lipoprotein composition
    M Boll
    Institute of Toxicology, GSF National Research Center for Environment and Health, , Neuherberg, Bundesrepublik Deutschland
    Z Naturforsch C 56:283-90. 2001
    ..1) CCl4 decreased secretion of very low density lipoproteins (VLDL) by about 85%, while high density lipoprotein (HDL) secretion was less affected (about 40%). The effect was concentration-dependent...
  78. ncbi Serum levels of apolipoprotein A-I, A-II and HDL-cholesterol in second half of normal pregnancy and in pregnancy complicated by pre-eclampsia
    U Rosing
    Department of Obstetrics and Gynecology, Karolinska Institutet, Huddinge University Hospital, Sweden
    Horm Metab Res 21:376-82. 1989
    Serum concentrations of Apolipoprotein A-I and A-II, (Apo A-1 and Apo A-II) HDL-cholesterol (HDL-C), Total Cholesterol (TC), triglycerides (TG) and lipoprotein electrophoresis were assayed serially in the second half of normal pregnancy (..
  79. ncbi Effects of cholesterol reduction on BP response to mental stress in patients with high cholesterol
    B H Sung
    Department of Medicine, State University of New York and Millard Fillmore Health Care System, Buffalo 14209, USA
    Am J Hypertens 10:592-9. 1997
    ..Lovastatin significantly altered lipid profiles (-26% total cholesterol, +8% HDL, -34% LDL)...
  80. ncbi [Changes in coronary vasodilation in hypertensive patients with angiographically normal coronary arteries]
    I Antony
    Service d'Explorations Fonctionnelles, INSERM U251, , Colombes
    Arch Mal Coeur Vaiss 87:1029-33. 1994
    ..All the patients had angiographically normal coronary arteries. Total serum cholesterol, triglycerides, HDL- and LDL-cholesterol were within normal range in all patients...
  81. ncbi Insulin resistance and abnormal electrocardiograms in patients with high blood pressure
    W H Sheu
    Division of Endocrinology and Metabolism, Tri-Service General Hospital, Taipei, Republic of China, Taiwan
    Am J Hypertens 5:444-8. 1992
    ..concentration lower then normal in hypertensive patients with an abnormal EKG, and the ratio of total to HDL cholesterol was higher in this subgroup...
  82. ncbi Plasma lipids, lipoproteins, and apolipoproteins in Nigerian diabetes mellitus, essential hypertension, and hypertensive-diabetic patients
    O O Oyelola
    Department of Chemical Pathology, College of Medical Sciences, Obafemi Awolowo University, Ile Ife, Osun State, Nigeria
    J Natl Med Assoc 87:113-8. 1995
    ..High-density lipoprotein cholesterol (HDL-C) was significantly lower; its related ratios, total/HDL-C and low-density lipoprotein cholesterol (LDL-C)/HDL-C ..
  83. ncbi Combining beta-adrenergic and peroxisome proliferator-activated receptor gamma stimulation improves lipoprotein composition in healthy moderately obese subjects
    Thomas A Hughes
    Health Science Center, Department of Medicine, University of Tennessee, Memphis, TN 38163, USA
    Metabolism 55:26-34. 2006
    Current pharmacological regimens for hypertriglyceridemia and low high-density lipoprotein (HDL) are limited to the peroxisome proliferator-activated receptor (PPAR) alpha activating fibrates, niacin, and statins...
  84. ncbi Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials
    Ronald P Mensink
    Department of Human Biology, Maastricht University, Maastricht, Netherlands
    Am J Clin Nutr 77:1146-55. 2003
    ..Fats, however, also affect HDL cholesterol, and the ratio of total to HDL cholesterol is a more specific marker of CAD than is LDL cholesterol.
  85. ncbi A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density li
    Jun Sasaki
    International University of Health and Welfare Graduate School of Public Health Medicine, Tagawa Municipal Hospital, Fukuoka, Japan
    Clin Ther 30:1089-101. 2008
    ..Recently, research interest has focused on modification of high-density lipoprotein cholesterol (HDL-C) levels for the potential prevention of cardiovascular events...
  86. ncbi Long-term safety and efficacy of a combination of niacin extended release and simvastatin in patients with dyslipidemia: the OCEANS study
    Richard H Karas
    Division of Cardiology, Molecular Cardiology Research Institute, Tufts Medical Center, Boston, Massachusetts, USA
    Am J Cardiovasc Drugs 8:69-81. 2008
    ..This fact has focused increased attention on treating abnormalities of non-high-density lipoprotein-cholesterol (non-HDL-C), HDL-C, and triglycerides in national guidelines and has intensified interest in combination therapy.
  87. ncbi HDL cholesterol response to GH replacement is associated with common cholesteryl ester transfer protein gene variation (-629C>A) and modified by glucocorticoid treatment
    Robin P F Dullaart
    Department of Endocrinology Laboratory Centre, University of Groningen and University Medical Centre Groningen, PO Box 30001, 9700 RB Groningen, The Netherlands
    Eur J Endocrinol 162:227-34. 2010
    ..and low-density lipoprotein cholesterol (LDL-C) in GH-deficient adults, but effects on high-density lipoprotein (HDL) cholesterol (HDL-C) are variable...
  88. ncbi Results of retrospective chart review to determine improvement in lipid goal attainment in patients treated by high-volume prescribers of lipid-modifying drugs
    Thomas A Stacy
    Total Therapeutic Management, Inc, 95 Chastain Rd, Suite 302, Kennesaw, GA 30144, USA
    J Manag Care Pharm 12:745-51. 2006
    ..low-density lipoprotein cholesterol (LDL-C) component of dyslipidemia and a secondary focus on the other components of dyslipidemia, such as low high-density lipoprotein cholesterol (HDL-C), high triglycerides (TGs), and high non-HDL-C.
  89. ncbi Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study
    Michael H Davidson
    Radiant Research, 515 North State Street, Suite 2700, Chicago, IL 60610, USA
    Clin Ther 29:1354-67. 2007
    ..with elevated serum triglyceride (TG) levels often have elevations in non-high-density lipoprotein cholesterol (non-HDL-C) levels as well...
  90. ncbi Secular trends in cholesterol lipoproteins and triglycerides and prevalence of dyslipidemias in an urban Indian population
    Rajeev Gupta
    Department of Medicine, Fortis Escorts Hospital, Jaipur 302017, India
    Lipids Health Dis 7:40. 2008
    ..Coronary heart disease is increasing in urban Indian subjects and lipid abnormalities are important risk factors. To determine secular trends in prevalence of various lipid abnormalities we performed studies in an urban Indian population...
  91. ncbi Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial
    Peter H Jones
    Section of Atherosclerosis and Lipid Research, Baylor College of Medicine, Houston, Texas 77030, USA
    Clin Ther 26:1388-99. 2004
    Non-high-density lipoprotein cholesterol (HDL-C), apolipoprotein (apo) B, and lipid and apolipoprotein ratios that include both atherogenic and antiatherogenic lipid components have been found to be strong predictors of coronary heart ..
  92. ncbi Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglycerides
    Geesje M Dallinga-Thie
    Department of Internal Medicine, University Medical Center Utrecht, Utrecht, The Netherlands
    Diabetes Care 27:1358-64. 2004
    Apolipoprotein (apo)C-III is a constituent of HDL (HDL apoC-III) and of apoB-containing lipoproteins (LpB:C-III)...
  93. ncbi Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis
    Stephen J Nicholls
    Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio 44195, USA
    JAMA 297:499-508. 2007
    ..However, no data exist describing the relationship between statin-induced changes in high-density lipoprotein cholesterol (HDL-C) and disease progression.
  94. ncbi Subpopulations of high density lipoproteins in homozygous and heterozygous Tangier disease
    B F Asztalos
    Lipid Metabolism Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, New England Medical Center, 711 Washington Street, Boston, MA 02111, USA
    Atherosclerosis 156:217-25. 2001
    Tangier disease (TD) is characterized by severe high-density lipoproteins (HDL) deficiency, hypercatabolism of HDL constituents, impaired cellular cholesterol efflux, and mutations in the gene of ATP-binding cassette 1 (ABC-1)...
  95. ncbi Cost effectiveness of treating low HDL-cholesterol in the primary prevention of coronary heart disease
    Joel W Hay
    Department of Pharmaceutical Economics and Policy, University of Southern California, Los Angeles, California 90089, USA
    Pharmacoeconomics 23:133-41. 2005
    A low serum level of high-density lipoprotein (HDL)-cholesterol is an independent risk factor for coronary heart disease (CHD)...
  96. ncbi Apolipoprotein A-II inhibits high density lipoprotein remodeling and lipid-poor apolipoprotein A-I formation
    Kerry Anne Rye
    Lipid Research Laboratory, Hanson Institute, Adelaide, South Australia 5000, Australia
    J Biol Chem 278:22530-6. 2003
    The high density lipoproteins (HDL) in human plasma are classified on the basis of apolipoprotein composition into those containing apolipoprotein (apo) A-I but not apoA-II, (A-I)HDL, and those containing both apoA-I and apoA-II, (A-I/A-..
  97. ncbi Apolipoprotein A-II, HDL metabolism and atherosclerosis
    Anne Tailleux
    Faculte de Pharmacie, Département d athérosclérose et INSERM U 545, Institut Pasteur, Universite Lille 2, 1, rue du Professeur Calmette, 59019 Cedex, Lille, France
    Atherosclerosis 164:1-13. 2002
    Apolipoprotein (Apo) A-I and apo A-II are the major apolipoproteins of HDL. It is clearly demonstrated that there are inverse relationships between HDL-cholesterol and apo A-I plasma levels and the risk of coronary heart disease (CHD) in ..
  98. ncbi The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney disease
    P Pennell
    Division of Nephrology and Hypertension R 126, Miller School of Medicine, University of Miami, P O Box 016960, Miami, FL 33101, USA
    Clin Nephrol 66:336-47. 2006
    ..lt; 100 mg/dl and, for patients with hypertriglyceridemia (> or = 200 mg/ dl), non-high-density lipoprotein (non-HDL) < 130 mg/dl, the latter to achieve very low-density lipoprotein (VLDL) < 30 mg/dl...
  99. ncbi Human secretory phospholipase A2 mediates decreased plasma levels of HDL cholesterol and apoA-I in response to inflammation in human apoA-I transgenic mice
    Uwe J F Tietge
    Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Arterioscler Thromb Vasc Biol 22:1213-8. 2002
    Plasma levels of high density lipoprotein (HDL) cholesterol and apolipoprotein (apo)A-I are decreased in inflammatory states...
  100. ncbi Significance of skeletal muscle properties on fitness, long-term physical training and serum lipids
    H O Tikkanen
    Department of Clinical Chemistry, Helsinki University Central Hospital, Finland
    Atherosclerosis 142:367-78. 1999
    ..may have a significant impact on physical activity, fitness level, serum high density lipoprotein cholesterol (HDL-C) concentration, and ultimately, on the risk of coronary heart disease (CHD)...

Research Grants104 found, 100 shown here

  1. THE ATHEROPROTECTIVE EFFECTS OF SR-BI
    Monty Krieger; Fiscal Year: 2004
    DESCRIPTION (Adapted from Investigator's Abstract): The HDL receptor, scavenger receptor, class B type I (SR-BI), mediates cellular delivery of HDL cholesterol by selective lipid uptake, a mechanism fundamentally different from that of ..
  2. Apo E mimetics reduce cholesterol and improve HDL function
    G M Anantharamaiah; Fiscal Year: 2010
    ..Recent advances in apoA-I mimetic peptides indicate the possibility of improving HDL functions...
  3. Structure of apolipoprotein A-I on defined states of HDL
    MICHAEL NOBUAKI ODA; Fiscal Year: 2010
    The plasma level of high density lipoprotein (HDL) is a primary indicator of clinical risk for the onset of atherosclerosis...
  4. Asthma Increases Vaso-occlusion in Sickle Cell Disease
    KIRKWOOD A contact PRITCHARD; Fiscal Year: 2010
    ..Additionally, OVA-sensitization increases proinflammatory high-density lipoprotein (HDL) levels in SCD mice, indicating that HDL from SCD+asthma mice is oxidatively modified to a greater extent than HDL ..
  5. Dynamics of LCAT activation and lipoprotein remodeling
    Jere P Segrest; Fiscal Year: 2011
    DESCRIPTION (provided by applicant): High density lipoproteins (HDL) are promising targets for pharmacological therapy of cardiovascular disease (CVD)...
  6. SR-BI: INFLUENCE OF APOA-II
    DENEYS VAN DER WESTHUYZEN; Fiscal Year: 2003
    DESCRIPTION: (Adapted from the Investigator's Abstract):HDL and apoA-I plasma levels are inversely related to coronary artery disease...
  7. Apolipoprotein A-I structure in high density lipoproteins
    W Davidson; Fiscal Year: 2007
    High density lipoprotein (HDL) and its major protein constituent, apolipoprotein (apo)A-l, play critical roles in the prevention of human cardiovascular disease, which claims nearly a million lives in the United States every year...
  8. Apolipoprotein A-I structure in high density lipoproteins
    W Sean Davidson; Fiscal Year: 2010
    High density lipoprotein (HDL) and its major protein constituent, apolipoprotein (apo)A-l, play critical roles in the prevention of human cardiovascular disease, which claims nearly a million lives in the United States every year...
  9. Structural Plasticity of ApoAI & Lipid-binding Activity
    Jianjun Wang; Fiscal Year: 2007
    ..Lipid-free apoAI conformation (Specific phospholipid-binding). (2). ApoAI on pre-beta-HDL (Specific cholesterol binding). (3). ApoAI on discoidal HDL (Specific LCAT activation). (4)...
  10. Structural Plasticity of ApoAI & Lipid-binding Activity
    Jianjun Wang; Fiscal Year: 2009
    ..Lipid-free apoAI conformation (Specific phospholipid-binding). (2). ApoAI on pre-beta-HDL (Specific cholesterol binding). (3). ApoAI on discoidal HDL (Specific LCAT activation). (4)...
  11. Pharmacogenetics of the Statin Response
    ERNST SCHAEFER; Fiscal Year: 2006
    ..are age, gender, elevated low density lipoprotein (LDL) cholesterol (C), decreased high density lipoprotein (HDL) C, hypertension, smoking, diabetes, elevated lipoprotein (a) or Lp(a) (LDL C> 50% reduction), and elevated C-..
  12. HDL Modulation of monocyte function in endotoxemia
    Geeta Datta; Fiscal Year: 2009
    ..leading to an increase in triglyceride (TG)-rich lipoproteins and a decrease in high density lipoprotein (HDL) levels in plasma...
  13. HDL Modulation of monocyte function in endotoxemia
    Geeta Datta; Fiscal Year: 2009
    ..leading to an increase in triglyceride (TG)-rich lipoproteins and a decrease in high density lipoprotein (HDL) levels in plasma...
  14. HDL Modulation of monocyte function in endotoxemia
    C Roger White; Fiscal Year: 2010
    ..leading to an increase in triglyceride (TG)-rich lipoproteins and a decrease in high density lipoprotein (HDL) levels in plasma...
  15. Cholesterol and Lymphatic Transport of Molecules and Cells
    Melody A Swartz; Fiscal Year: 2010
    ..vasculature and ultimately the liver depends not only on the loading of cholesterol onto high-density lipoprotein (HDL) particles within parenchymal tissues but also access of the HDL to the bloodstream...
  16. ATHEROSCLEROSIS PREVENTION IN MICE BY MUTANT APO A-1
    GODFREY GETZ; Fiscal Year: 2001
    DESCRIPTION (Adapted from Investigator's Abstract): An inverse correlation between HDL level and protection against atherosclerosis has emerged from human population studies and the study of transgenic mice...
  17. SR-BI MEDIATED SELECTIVE CHOLESTEROL ESTER UPTAKE
    FREDERICK DE BEER; Fiscal Year: 2005
    DESCRIPTION: There is interest in understanding the factors that regulate HDL and apoA-I levels in humans as these are inversely correlated with the risk for atherosclerotic vascular disease...
  18. Cholesterol Metabolism-Role of Apo A-I and SR-B1
    Jeffrey Pessin; Fiscal Year: 2005
    ..and cultured human cells indicate that this pathway plays a major role in the uptake of high density lipoprotein (HDL) CE into the liver and steroidogenic cells...
  19. Cholesterol Metabolism-Role of Apo A-I and SR-B1
    David Williams; Fiscal Year: 2003
    ..and cultured human cells indicate that this pathway plays a major role in the uptake of high density lipoprotein (HDL) CE into the liver and steroidogenic cells...
  20. HIGH DENSITY LIPOPROTEIN SUBSPECIES AND CORONARY DISEASE
    Bela Asztalos; Fiscal Year: 2003
    ..smoking, increased low density lipoprotein cholesterol (LDL-C), and decreased high density lipoprotein cholesterol (HDL-C)...
  21. HDL Dysfunction and Vascular Inflammation
    Kirkwood A Pritchard; Fiscal Year: 2010
    ..On the basis that apoA-l mimetics were designed to improve HDL function, we hypothesize that oxidative stress and inflammation induce HDL dysfunction, which in turn impairs ..
  22. Neurorestorative therapy of stroke with agents that increase HDL
    Jieli Chen; Fiscal Year: 2010
    High-density lipoprotein cholesterol (HDL-C) has a positive effect on endothelial cell and vascular wall function...
  23. Neurorestorative therapy of stroke with agents that increase HDL
    Jieli Chen; Fiscal Year: 2009
    High-density lipoprotein cholesterol (HDL-C) has a positive effect on endothelial cell and vascular wall function...
  24. MOLECULAR BASIS OF HIGH DENSITY LIPOPROTEIN DEFICIENCY
    ERNST SCHAEFER; Fiscal Year: 2001
    ..A plasma high density lipoprotein cholesterol (HDL-C) concentration of less than 35 mg/dl has been defined as a major independent CHD risk factor...
  25. Dietary Fat and HDL Metabolism
    Frank M Sacks; Fiscal Year: 2010
    Dietary Fat and HDL Metabolism...
  26. The Impact of Omega three Fatty Acids on Vascular Function and cIMT in HIV
    Christine A Wanke; Fiscal Year: 2010
    ..More recent data suggest that elevations in levels of triglycerides and decreased levels of HDL cholesterol may be equally important markers of CVD risk...
  27. The Impact of Omega three Fatty Acids on Vascular Function and cIMT in HIV
    Christine Wanke; Fiscal Year: 2009
    ..More recent data suggest that elevations in levels of triglycerides and decreased levels of HDL cholesterol may be equally important markers of CVD risk...
  28. MECHANISMS OF ACTIONS OF ALCOHOL AND OMEGA 3-FATTY ACIDS
    Raj Lakshman; Fiscal Year: 2004
    ..at the molecular level leading to defective glycosylation of apolipoprotein E (ApoE) and its association with HDL. Ethanol also affects sphingomyelin (SPM) and other phospholipids (PL) of HDL...
  29. Molecular and Funcitonal Analysis of Human A-I
    Vassilis I Zannis; Fiscal Year: 2010
    ApoA-I is the major protein component of HDL that is required both for the biogenesis and the functions of HDL. ApoA-I also contributes to the overall lipid homeostasis in the circulation and to atheroprotection...
  30. GENE-DIET EFFECTS ON LIPOPROTEIN METABOLISM
    Jan Breslow; Fiscal Year: 1993
    ..The following specific aims are proposed: A. Characterize how dietary fat and cholesterol influence HDL metabolism. In humans a high fat-high cholesterol diet increases HDL-C levels by increasing HDL apolipoprotein TR...
  31. PRESERVATION OF HDL FUNCTION DURING EARLY ATHEROGENESIS
    JOHN BIELICKI; Fiscal Year: 2002
    ..High density lipoproteins (HDL) promote the efflux of excess cholesterol from macrophage foam cells thus reversing the atherosclerotic process...
  32. Effects of particulate air pollution on HDL function and atherosclerosis
    JESUS ARAUJO; Fiscal Year: 2009
    This project aims to study the effects of air particulate matter on HDL function and atherosclerosis. Air pollution has been associated with significant adverse health effects leading to increased morbidity and mortality...
  33. Effects of particulate air pollution on HDL function and atherosclerosis
    JESUS ANTONIO ARAUJO; Fiscal Year: 2010
    This project aims to study the effects of air particulate matter on HDL function and atherosclerosis. Air pollution has been associated with significant adverse health effects leading to increased morbidity and mortality...